| Schedule (route) | Endpoint | Vehicle | Dose | Treated/Control (%) | Observations |
|---|---|---|---|---|---|
| Q01DX001 (ip) | median survival time | saline | 1.7 mg/kg/injection | 108.0 | Antitumor endpoint evaluated on day 30; 08/08 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 2.9 mg/kg/injection | 122.0 | Antitumor endpoint evaluated on day 30; 08/08 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 4.8 mg/kg/injection | 127.0 | Antitumor endpoint evaluated on day 30; 08/08 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 8.0 mg/kg/injection | 142.0 | Antitumor endpoint evaluated on day 30; 08/08 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 13.3 mg/kg/injection | 143.0 | Antitumor endpoint evaluated on day 30; 07/08 animals surviving on day 5 |